Patients undergoing hemodialysis thrice weekly appear to have no major benefit from a higher dialysis dose than that recommended by current U.S. guidelines or from the use of a high-flux membrane.
No takes yet. Share an insight, caveat, or question.
Eknoyan et al. (2002) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: